Effectiveness of BBV152/Covaxin and AZD1222/Covishield vaccines against severe COVID-19 and B.1.617.2/Delta variant in India, 2021: a multi-centric hospital-based case-control study

International Journal of Infectious Diseases(2022)

引用 24|浏览2
暂无评分
摘要
•Multi-centric hospital-based study was conducted across 11 cities in India.•Both Covishield and Covaxin confer high protection against severe COVID-19.•Both vaccines provide high protection against severe disease by the Delta strain.•Expansion of the two-dose vaccination coverage is key to reducing hospitalizations.
更多
查看译文
关键词
COVID-19 vaccines,BBV152/Covaxin,AZD1222/Covishield,Delta variant,Effectiveness,India
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要